Study in Lancet Digital Health represents the largest real-world evaluation of stroke AI imaging, encompassing data from more than 450,000 patients admitted to 107 NHS England hospitals over a 5-year period Brainomix 360 Stroke was deployed to 26 hospitals to evaluate the impact on stroke…
Tag: Brainomix
Brainomix Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
American Heart Association consortium advances development of evidence-based health tech solutions CHICAGO and OXFORD, England, Oct. 31, 2025 /PRNewswire/ — Brainomix, a global leader and pioneer of AI-powered imaging tools in stroke and lung fibrosis, today announced it has joined the…
Brainomix and 3DR Labs Partner to Advance Stroke Care in the US Through Clinically Validated AI Imaging Solution
OXFORD, England and CHICAGO, Ill., June 24, 2025 /PRNewswire/ — Today, Brainomix, a pioneer in stroke artificial intelligence (AI) imaging solutions, and 3DR Labs, the market leader in medical imaging post-processing services, announced a new strategic partnership to support acute stroke…
Brainomix Driving Treatment Decisions in Stroke: New Studies Presented at Leading European Stroke Conference
New evidence from the largest prospective evaluation of stroke AI imaging further validates Brainomix 360 Stroke impact on mechanical thrombectomy, expanding patient access across networks to the life-changing treatment The Oxford-based pioneer continues to drive cutting-edge research…
Brainomix Appoints Khush F. Mehta as Chair to Support Global Expansion and Commercial Growth
OXFORD, England and CHICAGO, May 21, 2025 /PRNewswire/ — Brainomix, a global leader in AI-powered imaging solutions in stroke and lung fibrosis, today announced the appointment of Khush F. Mehta as Chair of the Board. He succeeds Professor Jacqueline (‘Jackie’) Hunter CBE, who has served…
Brainomix Advances Stroke Care with Landmark FDA Clearance
Brainomix 360 unlocks expert-level insights from universally available non-contrast CT scans, helping stroke networks expand access to life-changing treatments OXFORD, England and CHICAGO, April 8, 2025 /PRNewswire/ — Brainomix, a global leader in AI-powered stroke imaging, has announced…
Brainomix Completes £14M ($18M) Series C Round to Advance Its Transformative AI Imaging Technology in Healthcare
University of Oxford spinout accelerates commercial expansion in the US of its innovative stroke AI imaging solution, with its demonstrated impact on vital treatments Funding will also support clinical uptake of its breakthrough solution in lung fibrosis OXFORD, England and CHICAGO, March…
Brainomix Partners with Medtronic to Enhance Stroke Care Across Western Europe
OXFORD, England, Feb. 27, 2025 /PRNewswire/ — Brainomix, a pioneer in stroke AI imaging software and European market leader, has announced a strategic partnership with Medtronic Neurovascular, a global leader in medical technology. The collaboration aims to enhance stroke care for…
New Data Presented at the International Stroke Conference Further Validates Treatment Impact of Brainomix 360
• This latest research builds upon the growing body of evidence demonstrating the unique impact of Brainomix’s AI-powered software to expand access to life-changing stroke treatments across networks OXFORD, England and CHICAGO, Feb. 4, 2025 /PRNewswire/ — Brainomix, an award-winning…
New Studies Validate the Value of Brainomix AI Technology Across US Stroke Networks
The studies presented this week at the Society of Neurointerventional Surgery (SNIS) underline the company’s rigorous evidence-based approach to developing and validating novel AI solutions that can help to optimize patient care across stroke networks. OXFORD, England and CHICAGO, July…



